199 related articles for article (PubMed ID: 19473295)
1. Abundant extracellular myelin in the meninges of patients with multiple sclerosis.
Kooi EJ; van Horssen J; Witte ME; Amor S; Bø L; Dijkstra CD; van der Valk P; Geurts JJ
Neuropathol Appl Neurobiol; 2009 Jun; 35(3):283-95. PubMed ID: 19473295
[TBL] [Abstract][Full Text] [Related]
2. Determination of the sequential degradation of myelin proteins by macrophages.
van der Goes A; Boorsma W; Hoekstra K; Montagne L; de Groot CJ; Dijkstra CD
J Neuroimmunol; 2005 Apr; 161(1-2):12-20. PubMed ID: 15748939
[TBL] [Abstract][Full Text] [Related]
3. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
Kerlero de Rosbo N; Hoffman M; Mendel I; Yust I; Kaye J; Bakimer R; Flechter S; Abramsky O; Milo R; Karni A; Ben-Nun A
Eur J Immunol; 1997 Nov; 27(11):3059-69. PubMed ID: 9394837
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells.
Serafini B; Rosicarelli B; Magliozzi R; Stigliano E; Capello E; Mancardi GL; Aloisi F
J Neuropathol Exp Neurol; 2006 Feb; 65(2):124-41. PubMed ID: 16462204
[TBL] [Abstract][Full Text] [Related]
5. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis.
Warren KG; Catz I; Johnson E; Mielke B
Ann Neurol; 1994 Mar; 35(3):280-9. PubMed ID: 7510098
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis and Alzheimer's disease.
Dal Bianco A; Bradl M; Frischer J; Kutzelnigg A; Jellinger K; Lassmann H
Ann Neurol; 2008 Feb; 63(2):174-83. PubMed ID: 17924575
[TBL] [Abstract][Full Text] [Related]
7. Redox regulation of cytokine-mediated inhibition of myelin gene expression in human primary oligodendrocytes.
Jana M; Pahan K
Free Radic Biol Med; 2005 Sep; 39(6):823-31. PubMed ID: 16109311
[TBL] [Abstract][Full Text] [Related]
8. In vivo detection of myelin proteins in cervical lymph nodes of MS patients using ultrasound-guided fine-needle aspiration cytology.
Fabriek BO; Zwemmer JN; Teunissen CE; Dijkstra CD; Polman CH; Laman JD; Castelijns JA
J Neuroimmunol; 2005 Apr; 161(1-2):190-4. PubMed ID: 15748959
[TBL] [Abstract][Full Text] [Related]
9. Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients.
Sarchielli P; Di Filippo M; Candeliere A; Chiasserini D; Mattioni A; Tenaglia S; Bonucci M; Calabresi P
J Neuroimmunol; 2007 Aug; 188(1-2):146-58. PubMed ID: 17628700
[TBL] [Abstract][Full Text] [Related]
10. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
Kerlero de Rosbo N; Mendel I; Ben-Nun A
Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
Henderson AP; Barnett MH; Parratt JD; Prineas JW
Ann Neurol; 2009 Dec; 66(6):739-53. PubMed ID: 20035511
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis.
Karni A; Bakimer-Kleiner R; Abramsky O; Ben-Nun A
Arch Neurol; 1999 Mar; 56(3):311-5. PubMed ID: 10190821
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
Kuhlmann T; Lucchinetti C; Zettl UK; Bitsch A; Lassmann H; Brück W
Glia; 1999 Oct; 28(1):34-9. PubMed ID: 10498820
[TBL] [Abstract][Full Text] [Related]
14. Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.
Gardner C; Magliozzi R; Durrenberger PF; Howell OW; Rundle J; Reynolds R
Brain; 2013 Dec; 136(Pt 12):3596-608. PubMed ID: 24176976
[TBL] [Abstract][Full Text] [Related]
15. Myelin-associated glycoprotein in multiple sclerosis lesions: a quantitative and qualitative analysis.
Möller JR; Yanagisawa K; Brady RO; Tourtellotte WW; Quarles RH
Ann Neurol; 1987 Oct; 22(4):469-74. PubMed ID: 2449119
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of myelin-specific proteins in pt rabbits.
Domańska-Janik K; Sypecka J; Taraszewska A
Folia Neuropathol; 1997; 35(1):1-7. PubMed ID: 9161094
[TBL] [Abstract][Full Text] [Related]
17. Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis.
Hafler DA; Benjamin DS; Burks J; Weiner HL
J Immunol; 1987 Jul; 139(1):68-72. PubMed ID: 2438352
[TBL] [Abstract][Full Text] [Related]
18. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis.
Kaushansky N; Eisenstein M; Zilkha-Falb R; Ben-Nun A
Autoimmun Rev; 2010 Feb; 9(4):233-6. PubMed ID: 19683076
[TBL] [Abstract][Full Text] [Related]
19. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
[TBL] [Abstract][Full Text] [Related]
20. Early cellular events in multiple sclerosis. Intimations of an extrinsic myelinolytic antigen.
Gay FW
Clin Neurol Neurosurg; 2006 Mar; 108(3):234-40. PubMed ID: 16364541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
